# Split-face Comparison Study to Assess ELAPR Compared to Juvéderm® for the Treatment of Nasolabial Folds

> **NCT01463657** · PHASE1,PHASE2 · COMPLETED · sponsor: **Elastagen Pty Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Aging

## Interventions

- **DEVICE:** Juvéderm® Ultra Plus
- **DEVICE:** ELAPR002

## Key facts

- **NCT ID:** NCT01463657
- **Lead sponsor:** Elastagen Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01463657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01463657, "Split-face Comparison Study to Assess ELAPR Compared to Juvéderm® for the Treatment of Nasolabial Folds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01463657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*